Concepedia

Annemieke Willemze

AW

Statistics

Publications

11

Citations

578

H-Index

10

Active since

1997

Affiliations

Sanofi (Netherlands)(Current)

Sanofi (France)

Sanofi (United States)

Leiden University Medical Center

University of Washington

Annemieke Willemze is an author at Sanofi (Netherlands) specializing in epidemiology, thrombosis, and drug resistance.

ORCID

Top concepts

Publications per year

1997–2023

11

Publications

11

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

Annette von Drygalski, Pratima Chowdary, Roshni Kulkarni et al. · New England Journal of Medicine · 2023 · 160 citations · Full text

Aberrant Chemokine Receptor Expression and Chemokine Production by Langerhans Cells Underlies the Pathogenesis of Langerhans Cell Histiocytosis

Nicola Annels, Cristiana E.T. da Costa, Frans A. Prins et al. · The Journal of Experimental Medicine · 2003 · 157 citations · Full text

Chemokine/chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: Differential roles for CCR2, CCR5, CXCR4 and CXCR7

Claudia M.J.M. Faaij, Annemieke Willemze, Tom Révész et al. · Pediatric Blood & Cancer · 2010 · 62 citations

The association of haemophilic arthropathy with Health‐Related Quality of Life: a<i>post hoc</i>analysis

Kathelijn Fischer, P. de Kleijn, Claude Négrier et al. · Haemophilia · 2016 · 39 citations · Full text

Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat-dose study

Toshko Lissitchkov, Annemieke Willemze, Suresh Katragadda et al. · Blood Advances · 2021 · 39 citations · Full text

, , +14

Rows per page

1–5 of 11